Osaka, Japan

Masakuni Kurono

USPTO Granted Patents = 6 


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Masakuni Kurono: Pioneering Research in Cancer and Infectious Disease Therapies

Introduction: Masakuni Kurono, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of pharmaceuticals, particularly in the area of cancer and infectious disease treatments. With a remarkable portfolio of six patents, Kurono is recognized for his innovative research and dedication to advancing medical science.

Latest Patents: Among Kurono's latest inventions is a STING agonistic compound, described as a drug or agent that features a compound with agonistic activity to STING as its active ingredient. This compound is represented by a specific general formula (I-1), allowing for its application in suppressing the progression and recurrence of cancer, as well as in the treatment of infectious diseases. The development of such compounds showcases Kurono's commitment to finding new solutions within the pharmaceutical industry.

Career Highlights: Throughout his career, Masakuni Kurono has served at Ono Pharmaceutical Co., Ltd., where he has played a pivotal role in various research initiatives. His innovative spirit and technical expertise have significantly impacted the company's portfolio and research capabilities.

Collaborations: In his pursuit of groundbreaking medical solutions, Kurono has collaborated with esteemed colleagues, including Shingo Yamamoto and Shingo Hotta. These partnerships have fostered a dynamic research environment, enabling the team to explore novel therapeutic avenues and enhance their collective contributions to science.

Conclusion: Masakuni Kurono stands out as a dedicated inventor whose work is instrumental in addressing critical health challenges. His patents, particularly in the STING agonistic compound area, reflect a commitment to innovation that not only propels research forward but also offers hope for effective treatments in the fight against cancer and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…